# Veterinary blood culture diagnostic testing: methodology and results from a German single-center study on dogs (2014-2022)

**Authors:** Teresa Sandbrink, Antina Lübke-Becker, Caroline Robé, Marcus Fulde, Myriam Antonia Knopf, Roswitha Merle, Christiane Weingart, Uwe Rösler, Stefan Schwarz, Barbara Kohn

PMC · DOI: 10.1093/jvimsj/aalaf057 · Journal of Veterinary Internal Medicine · 2026-01-21

## TL;DR

This study analyzed blood culture results in dogs at a German hospital from 2014 to 2022, finding a 13.6% yield of clinically relevant bacteria and highlighting factors affecting diagnostic accuracy.

## Contribution

The study identifies management factors affecting blood culture yield and contamination in veterinary medicine, emphasizing antimicrobial resistance and processing delays.

## Key findings

- Blood culture yield was 13.6% with a contamination rate of 1.9%.
- Multidrug-resistant and methicillin-resistant bacteria were frequently isolated.
- Antimicrobial pretreatment increased the likelihood of multidrug-resistant isolates.

## Abstract

Blood cultures (BCs) are the gold standard for identifying bacterial bloodstream infections and are vital for directing antimicrobial treatment.

Characterize BC results and diagnostic testing in veterinary medicine. Pathogen identification (ID) results, antimicrobial susceptibility testing (AST) results, and management factors were investigated to identify optimization opportunities.

A total of 750 BCs from 687 dogs presented between January 2014 and September 2022 at a German teaching hospital, with 102 positive BCs from 101 dogs.

Retrospective analysis of historical data. A BC system suitable for aerobic and anaerobic pathogens was used.

Blood culture yield (clinically relevant growth in 102/750 BCs) was 13.6%, and the contamination rate was 1.9%. Commonly isolated pathogens were Enterobacterales (n = 15/25 multidrug-resistant), coagulase-positive staphylococci (n = 3/23 methicillin-resistant), beta-hemolytic streptococci (n = 19), and obligate anaerobes (n = 22). Polymicrobial growth occurred in 8 BCs (7.8%). Median duration of the preanalytical phase (sampling until receipt in laboratory) was 1 day (interquartile range [IQR], 1-2), from receipt in laboratory until ID results 1 day (IQR, 1-2), and until AST results 2 days (IQR, 2-4). The preanalytical phase of BCs taken on weekends was a median of 1 day longer (P < .001). Dogs treated with antimicrobials within 7 days before sampling were 10.74 times more likely to yield a multidrug-resistant isolate (95% confidence interval [CI], 3.62-31.86).

Improving BC processing requires addressing the management factors BC yield, contamination rate, weekend sampling, and antimicrobial pretreatment. Detection of resistant bacteria emphasizes the need for more rapid processing to shorten the time to optimized antimicrobial treatment.

## Full-text entities

- **Genes:** MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}
- **Diseases:** coagulase-positive staphylococci (MESH:D000377), CoNS (MESH:D013203), BSIs (MESH:D018805), septic shock (MESH:D012772), septic (MESH:D001170), BCs (MESH:D006402), CLSI (MESH:D007757), infection (MESH:D007239), fever (MESH:D005334), skin (MESH:D012871), MDR (MESH:D018088), shock (MESH:D012769)
- **Chemicals:** imipenem (MESH:D015378), ampicillin (MESH:D000667), oxacillin (MESH:D010068), CO2 (MESH:D002245), beta-lactams (MESH:D047090), penicillin (MESH:D010406), tetracycline (MESH:D013752), ESBLs (-), fluoroquinolone (MESH:D024841), cephalosporins (MESH:D002511), trimethoprim (MESH:D014295), macrolides (MESH:D018942), carbapenems (MESH:D015780), tetracyclines (MESH:D013754), Methicillin (MESH:D008712), aminoglycosides (MESH:D000617), doxycycline (MESH:D004318), cefoxitin (MESH:D002440), spectinomycin (MESH:D000198), lincosamides (MESH:D055231), sulfonamides (MESH:D013449)
- **Species:** Equus caballus (domestic horse, species) [taxon 9796], Bacillus (genus) [taxon 55087], Clostridium haemolyticum (species) [taxon 84025], Streptococcus canis (species) [taxon 1329], Staphylococcus pseudintermedius (species) [taxon 283734], Proteus mirabilis (species) [taxon 584], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Pasteurella canis (species) [taxon 753], Leuconostoc lactis (species) [taxon 1246], Staphylococcus intermedius (species) [taxon 1285], Enterobacterales (order) [taxon 91347], Bdellovibrio sp. ETA (species) [taxon 242951], Streptococcus pneumoniae (species) [taxon 1313], Solanum coagulans (species) [taxon 395917], Escherichia coli (E. coli, species) [taxon 562], Clostridium perfringens (species) [taxon 1502], Enterobacter cloacae complex (species group) [taxon 354276], Canis lupus familiaris (dog, subspecies) [taxon 9615], Klebsiella pneumoniae (species) [taxon 573], Acinetobacter ursingii (species) [taxon 108980], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Erysipelothrix rhusiopathiae (species) [taxon 1648]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881953/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881953/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881953/full.md

---
Source: https://tomesphere.com/paper/PMC12881953